A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer
Michael A. Carducci, Fred Saad, Per Anders Abrahamsson, David P. Dearnaley, Claude C. Schulman, Scott A. North, Darryl J. Sleep, Jeffrey D. Isaacson, Joel B. Nelson
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer'. Together they form a unique fingerprint.